Published in Br J Pharmacol on February 01, 2003
Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants. Naunyn Schmiedebergs Arch Pharmacol (2013) 1.46
β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function. Kidney Int (2016) 1.38
Tools to study beta3-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (2007) 1.14
Direct evidence of nitric oxide release from neuronal nitric oxide synthase activation in the left ventricle as a result of cervical vagus nerve stimulation. J Physiol (2009) 1.08
Mechanisms of beta 3-adrenoceptor-induced eNOS activation in right atrial and left ventricular human myocardium. Br J Pharmacol (2004) 1.02
beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ current. J Clin Invest (2008) 1.01
Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system. J Mol Cell Cardiol (2010) 0.98
Human atrial β(1L)-adrenoceptor but not β₃-adrenoceptor activation increases force and Ca(2+) current at physiological temperature. Br J Pharmacol (2011) 0.86
Genetically changed mice with chronic deficiency or overexpression of the beta-adrenoceptors--what can we learn for the therapy of heart failure? Pflugers Arch (2007) 0.85
Mitochondriocentric pathway to cardiomyocyte necrosis in aldosteronism: cardioprotective responses to carvedilol and nebivolol. J Cardiovasc Pharmacol (2011) 0.85
Tissue functions mediated by beta(3)-adrenoceptors-findings and challenges. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.84
β3-adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.83
Increased Ca2+ sensitivity and protein expression of SERCA 2a in situations of chronic beta3-adrenoceptor deficiency. Pflugers Arch (2006) 0.82
Are there functional β₃-adrenoceptors in the human heart? Br J Pharmacol (2011) 0.80
[On the function of beta3-adrenoceptors in the human heart: signal transduction, inotropic effect and therapeutic prospects]. Wien Med Wochenschr (2006) 0.78
Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem (1998) 4.77
Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature (1984) 3.64
Functional beta3-adrenoceptor in the human heart. J Clin Invest (1996) 2.32
Beta 3 and atypical beta-adrenoceptors. Med Res Rev (1993) 2.21
Nitric oxide and cardiac function. Circ Res (1996) 2.01
Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the alpha- and beta-subtypes. Br J Pharmacol (1988) 1.97
Is the adipocyte beta-adrenoceptor a prototype for the recently cloned atypical 'beta 3-adrenoceptor'? Trends Pharmacol Sci (1990) 1.82
The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest (1998) 1.66
Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation (2001) 1.58
Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat. Br J Pharmacol (1996) 1.52
Coexistence of three beta-adrenoceptor subtypes in white fat cells of various mammalian species. Eur J Pharmacol (1991) 1.40
Determination and bioimaging method for nitric oxide in biological specimens by diaminofluorescein fluorometry. Anal Biochem (2000) 1.29
Molecular and functional characterization of the non-isopeptide-selective ETB receptor in endothelial cells. Receptor coupling to nitric oxide synthase. J Biol Chem (1994) 1.25
Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta. Br J Pharmacol (1999) 1.16
Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc Res (1999) 1.10
The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord (1999) 1.08
Peripheral vascular effects of beta-3 adrenergic receptor stimulation in conscious dogs. J Pharmacol Exp Ther (1994) 1.07
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog. J Pharmacol Exp Ther (1994) 1.04
The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms. J Pharmacol Exp Ther (1992) 1.03
Effect of inotropic interventions on contraction and Ca2+ transients in the human heart. J Appl Physiol (1985) (1997) 0.99
Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists. J Pharmacol Exp Ther (1999) 0.98
Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man. Br J Clin Pharmacol (1994) 0.97
Functional and molecular evidence for beta 1-, beta 2- and beta 3- adrenoceptors in human colon. Br J Pharmacol (1997) 0.96
Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium. Br J Pharmacol (2001) 0.96
Further heterogeneity of the beta-adrenoceptor. The phenylethanolaminotetralines: new selective agonists for atypical beta-adrenoceptors. Trends Pharmacol Sci (1990) 0.93
Positive chronotropic and inotropic responses to BRL 37344, a beta 3-adrenoceptor agonist in isolated, blood-perfused dog atria. Eur J Pharmacol (1993) 0.91
The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities. J Pharmacol Exp Ther (1998) 0.91
Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. J Lipid Res (1996) 0.89
Pharmacological characteristics and species-related variations of beta 3-adrenergic receptors. Fundam Clin Pharmacol (1995) 0.88
Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy. Am Heart J (1992) 0.88
Different beta-adrenoceptor-effector coupling in human ventricular and atrial myocardium. Eur J Clin Invest (1991) 0.87
Ischemia increases detectable endothelial nitric oxide synthase in rat and human myocardium. Nitric Oxide (2001) 0.85
Beta 3-adrenoceptors and the regulation of metabolism in adipose tissues. Biochem Soc Trans (1996) 0.85
The potential significance of beta 3 adrenergic receptors. J Clin Invest (1995) 0.85
Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cAMP-dependent pathway. Biochem Biophys Res Commun (1998) 0.85
The effect of xamoterol in failing human myocardium. Eur Heart J (1990) 0.80
Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res (1993) 6.33
Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucleic Acids Res (1992) 5.98
NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol Cell (2000) 3.60
Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol (1999) 2.94
An improved technique for the in situ detection of DNA after polymerase chain reaction amplification. Am J Pathol (1991) 2.32
Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol (2001) 2.13
Risk stratification in heart surgery: comparison of six score systems. Eur J Cardiothorac Surg (2000) 2.03
A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant (2009) 1.76
Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein. J Cell Biol (1998) 1.66
Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J Exp Med (1998) 1.65
Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol (1999) 1.63
Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice. Mol Cell Biol (2001) 1.51
High-density multiplex detection of nucleic acid sequences: oligonucleotide ligation assay and sequence-coded separation. Nucleic Acids Res (1994) 1.41
Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA. Am Heart J (1999) 1.41
Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery. Thorac Cardiovasc Surg (2002) 1.40
Molecular toxicology of sulfur mustard-induced cutaneous inflammation and blistering. Toxicology (2009) 1.36
The phosphate content of Escherichia coli alkaline phosphatase and its effect on stopped flow kinetic studies. J Biol Chem (1973) 1.26
Cardiac surgery in patients with end-stage renal disease: 10-year experience. Ann Thorac Surg (2000) 1.26
Identification and characterization of embryonic stem cell-derived pacemaker and atrial cardiomyocytes. FASEB J (2005) 1.24
Acute effects of sulfur mustard injury--Munich experiences. Toxicology (2009) 1.23
Importance of different variables for enhancing in situ detection of PCR-amplified DNA. PCR Methods Appl (1993) 1.22
Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer (1998) 1.21
Regulation of the L-type Ca2+ channel during cardiomyogenesis: switch from NO to adenylyl cyclase-mediated inhibition. FASEB J (1999) 1.21
Differentiation and integrity of cardiac muscle cells are impaired in the absence of beta 1 integrin. J Cell Sci (1996) 1.19
Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure. Circulation (1999) 1.11
Deficiency of beta 1 integrins in teratoma interferes with basement membrane assembly and laminin-1 expression. Exp Cell Res (1998) 1.08
Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27. J Mol Med (Berl) (2004) 1.08
Cardiac specific expression of the green fluorescent protein during early murine embryonic development. FEBS Lett (1998) 1.05
Loss of annexin A7 leads to alterations in frequency-induced shortening of isolated murine cardiomyocytes. Mol Cell Biol (2001) 1.04
Myocardial edema, left ventricular function, and pulmonary hypertension. J Appl Physiol (1985) (1995) 1.03
Beta-blockade versus Buckberg blood-cardioplegia in coronary bypass operation. Eur J Cardiothorac Surg (1999) 1.01
Effects of strength and endurance training on brain-derived neurotrophic factor and insulin-like growth factor 1 in humans. Horm Metab Res (2008) 1.00
Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction. Clin Res Cardiol (2007) 0.99
Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol (2007) 0.97
Different effect of the Ca(2+) sensitizers EMD 57033 and CGP 48506 on cross-bridge cycling in human myocardium. J Pharmacol Exp Ther (2000) 0.97
Epidemiology of Peyronie's disease. Int J Impot Res (2002) 0.97
LMR spectroscopy: a new sensitive method for on-line recording of nitric oxide in breath. J Appl Physiol (1985) (1999) 0.97
Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia (1995) 0.96
Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium. Br J Pharmacol (2001) 0.96
Nitric oxide modulates sympathetic neurotransmission at the prejunctional level. Microsc Res Tech (1994) 0.95
Establishment of ionic channels and signalling cascades in the embryonic stem cell-derived primitive endoderm and cardiovascular system. Cells Tissues Organs (1999) 0.93
Interference by cellular phones with permanent implanted pacemakers: an update. Europace (2004) 0.93
Impact of exercise on neuroplasticity-related proteins in spinal cord injured humans. Neuroscience (2008) 0.93
Healing of onlay mandibular bone grafts covered with collagen membrane or bovine bone substitutes: a microscopical and immunohistochemical study in the sheep. Int J Oral Maxillofac Surg (2008) 0.93
Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial. Mult Scler (2012) 0.92
Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease--a stereological approach. Neurobiol Dis (2000) 0.92
The nucleotide and acyl group content of native rabbit muscle glyceraldehyde 3-phosphate dehydrogenase. J Biol Chem (1971) 0.92
Surgical repair of a large residual atrial septal defect after transcatheter closure. Ann Thorac Surg (1997) 0.92
Endostatin, the proteolytic fragment of collagen XVIII, induces vasorelaxation. Circ Res (2006) 0.91
Inhibition of phosphatidylinositol-3-kinase blocks development of functional embryonic cardiomyocytes. Exp Cell Res (1999) 0.91
Hepatitis B virus particles contain a polypeptide encoded by the largest open reading frame: a putative reverse transcriptase. J Virol (1988) 0.90
Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein. Eur J Neurosci (1999) 0.90
Irreversible inflammation is associated with decreased levels of the alpha1-, beta1-, and alpha2-subunits of sGC in human odontoblasts. J Dent Res (2011) 0.89
Risk stratification models fail to predict hospital costs of cardiac surgery patients. Z Kardiol (2005) 0.89
[Vasculitis with anemia infarcts of the villi of the synovial membrane in rheumatoid arthritis]. Z Rheumatol (1989) 0.89
Effect of resistance exercise on serum levels of growth factors in humans. Horm Metab Res (2010) 0.88
SERCA2a activity correlates with the force-frequency relationship in human myocardium. Am J Physiol Heart Circ Physiol (2000) 0.88
Beta1 integrin deficiency impairs migration and differentiation of mouse embryonic stem cell derived neurons. Neurosci Lett (1998) 0.88
Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder. J Urol (2001) 0.88
Introduction to PCR/OLA/SCS, a multiplex DNA test, and its application to cystic fibrosis. Genet Test (1997) 0.87
Expression of inducible nitric oxide synthase (iNOS/NOS II) in the cochlea of guinea pigs after intratympanical endotoxin-treatment. Brain Res (1999) 0.87
Cooling gradients and formation of gaseous microemboli with cardiopulmonary bypass: an echocardiographic study. Ann Thorac Surg (1997) 0.87
Nitric oxide synthase inhibitor suppresses the ototoxic side effect of cisplatin in guinea pigs. Anticancer Drugs (2000) 0.87
Functional interaction of caveolin-1 and eNOS in myocardial capillary endothelium revealed by immunoelectron microscopy. J Histochem Cytochem (2001) 0.86
Regulation of extracellular matrix compounds involved in angiogenic processes in short- and long-track elite runners. Scand J Med Sci Sports (2009) 0.86
Nitric oxide, a key signaling molecule in the murine early embryonic heart. FASEB J (2004) 0.86
Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer. Urology (1999) 0.86
Thiol-containing cross-linking agent with enhanced steric hindrance. Bioconjug Chem (1991) 0.86
Ischemia increases detectable endothelial nitric oxide synthase in rat and human myocardium. Nitric Oxide (2001) 0.85
Nitric oxide based influence of nitrates on micturition in patients with benign prostatic hyperplasia. Int Urol Nephrol (1999) 0.85
Increased expression of isoform 1 of the sarcoplasmic reticulum Ca(2+)-release channel in failing human heart. Circulation (2001) 0.85
Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial. Curr Med Res Opin (2004) 0.85
Short intensive exercise increases the migratory activity of mesenchymal stem cells. Br J Sports Med (2007) 0.85
Effects of myocardial edema on the development of myocardial interstitial fibrosis. Microcirculation (2000) 0.84
[Detection of nitric oxide synthases in physiological and pathophysiological processes of the nasal mucosa]. HNO (2000) 0.84
Overexpression of sorcin enhances cardiac contractility in vivo and in vitro. J Mol Cell Cardiol (2005) 0.84
Effect of body repositioning after venous air embolism. An echocardiographic study. Anesthesiology (1997) 0.84
Soluble guanylate cyclase and cGMP-dependent protein kinase I expression in the human corpus cavernosum. Int J Impot Res (2000) 0.84
Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardium. J Cardiovasc Pharmacol (1998) 0.84
8-Isoprostane is a dose-related biomarker for photo-oxidative ultraviolet (UV) B damage in vivo: a pilot study with personal UV dosimetry. Br J Dermatol (2006) 0.84
Intracoronary shunt insertion prevents myocardial stunning in a juvenile porcine MIDCAB model absent of coronary artery disease. Eur J Cardiothorac Surg (1999) 0.83
Long-term endurance exercise decreases antiangiogenic endostatin signalling in overweight men aged 50-60 years. Br J Sports Med (2007) 0.83
Priming of cardiopulmonary bypass with human albumin or Ringer lactate: effect on colloid osmotic pressure and extravascular lung water. Br J Anaesth (1991) 0.83
Acute metabolic, hormonal, and psychological responses to different endurance training protocols. Horm Metab Res (2013) 0.83
[Is measuring by portable heart rate monitors (sport watches) dependable in patients with an implanted pacemaker?]. Dtsch Med Wochenschr (2005) 0.82
Testosterone-propionate impairs the response of the cardiac capillary bed to exercise. Med Sci Sports Exerc (2000) 0.82
Exercise-induced adaptations of cardiac redox homeostasis and remodeling in heterozygous SOD2-knockout mice. J Appl Physiol (1985) (2011) 0.82
Effect of cyclopiazonic acid on the force-frequency relationship in human nonfailing myocardium. J Pharmacol Exp Ther (1997) 0.82